Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant Human ACTA1 protein, GST-tagged

Cat.No. : ACTA1-306H
Product Overview : Recombinant Human ACTA1 protein(NP_001091.1)(1-377 aa) was fused to GST Tag and expressed in E.coli.
Unit
Price
Qty
  • Specification
  • Gene Information
  • Related Products
Source : E.coli
Species : Human
Tag : GST
Form : The purified protein was Lyophilized from sterile PBS (58mM Na2HPO4,17mM NaH2PO4, 68mM NaCl, pH8.). 5 % trehalose and 5 % mannitol are added as protectants before lyophilization.
Protein length : 1-377 aa
AA Sequence : MCDEDETTALVCDNGSGLVKAGFAG DDAPRAVFPSIVGRPRHQGVMVGMG QKDSYVGDEAQSKRGILTLKYPIEH GIITNWDDMEKIWHHTFYNELRVAP EEHPTLLTEAPLNPKANREKMTQIM FETFNVPAMYVAIQAVLSLYASGRT TGIVLDSGDGVTHNVPIYEGYALPH AIMRLDLAGRDLTDYLMKILTERGY SFVTTAEREIVRDIKEKLCYVALDF ENEMATAASSSSLEKSYELPDGQVI TIGNERFRCPETLFQPSFIGMESAG IHETTYNSIMKCDIDIRKDLYANNV MSGGTTMYPGIADRMQKEITALAPS TMKIKIIAPPERKYSVWIGGSILAS LSTFQQMWITKQEYDEAGPSIVHRK CF
Purity : 85%, by SDS-PAGE with Coomassie Brilliant Blue staining.
Stability : Store for up to 12 months at -20°C to -80°C as lyophilized powder.
Storage : Short-term storage: Store at 2-8°C for (1-2 weeks).
Long-term storage: Aliquot and store at -20°C to -80°C for up to 3 months, buffer containing 50% glycerol is recommended for reconstitution. Avoid repeat freeze-thaw cycles.
Reconstitution : Reconstitute at 0.25 µg/μl in 200 μl sterile water for short-term storage.
Reconstitution with 200 μl 50% glycerol solution is recommended for longer term storage (see Stability and Storage for more details).
If a different concentration is needed for your purposes please adjust the reconstitution volume as required (please note: the ion concentration of the final solution will vary according to the volume used).
Note: Centrifuge vial before opening. When reconstituting, gently pipet and wash down the sides of the vial to ensure full recovery of the protein into solution.
Gene Name : ACTA1 actin, alpha 1, skeletal muscle [ Homo sapiens ]
Official Symbol : ACTA1
Synonyms : ACTA1; actin, alpha 1, ACTA; ASMA; CFTD; MPFD; NEM1; NEM2; NEM3; CFTD1; CFTDM;
Gene ID : 58
mRNA Refseq : NM_001100.3
Protein Refseq : NP_001091.1
MIM : 102610
UniProt ID : P68133

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (20)

Ask a question
What were the findings when transgenic mice expressing ACTA1(D286G) were created? 12/04/2022

The Tg(ACTA1)(D286G) mice exhibited decreased activity levels, weaker skeletal muscles, and pathological lesions similar to those observed in human patients. However, unlike the patients, the mice had a normal lifespan.

What is the function of the ACTA1 protein? 07/11/2022

The ACTA1 protein, also known as skeletal muscle α-actin, plays a crucial role in muscle contraction and the maintenance of muscle structure. It is a key component of the sarcomeres, the structural units of muscle fibers.

What significance do the ringbinden fibers have in relation to ACTA1 mutations? 04/10/2022

The presence of ringbinden fibers in the mouse models suggests that patients with ringbinden fibers of unknown genetic origin should be considered for ACTA1 mutation screening, indicating a possible link between these features and ACTA1 mutations.

How is ACTA1 inhibited by PAX3-FOXO1 in ARMS? 01/25/2022

ACTA1 is inhibited by PAX3-FOXO1 both at the transcriptional level and the protein level. This inhibition occurs through the RhoA-MKL1-SRF signaling pathway.

What techniques can be used to study the ACTA1 protein? 12/18/2021

Researchers employ various techniques to study the ACTA1 protein, such as immunohistochemistry, immunoblotting, and mass spectrometry. These methods help identify the presence, abundance, and localization of ACTA1 in muscle tissues or cells.

How do mutations in the ACTA1 gene contribute to Nemaline myopathy (NM)? 06/06/2021

Mutations in the ACTA1 gene account for a significant proportion of NM cases. Most of these mutations are missense mutations, which cause autosomal dominant NM by producing an abnormal protein. However, about 10% of ACTA1 gene mutations are associated with autosomal recessive NM, resulting in loss of protein function.

Are there any known interacting proteins or partners of ACTA1? 01/13/2021

Yes, the ACTA1 protein interacts with other proteins involved in muscle function and structure. For example, it forms complexes with other actin-binding proteins, such as myosin and tropomyosin, to regulate muscle contraction.

What is the relationship between mutations in the ACTA1 gene and congenital myopathies? 08/06/2020

Mutations in the skeletal muscle α-actin gene (ACTA1) cause various congenital myopathies, resulting in severe skeletal muscle weakness in most patients.

What is the difference in inheritance patterns between dominant and recessive ACTA1 gene mutations? 05/23/2020

The majority of ACTA1 gene mutations cause autosomal dominant NM, meaning a single abnormal copy of the gene is sufficient to cause the disorder. In contrast, approximately 10% of ACTA1 gene mutations lead to autosomal recessive NM, requiring two copies of the mutated gene (one from each parent) to manifest the disorder.

How does the RhoA-MKL1-SRF signaling pathway impact the inhibition of ACTA1? 04/03/2020

The RhoA-MKL1-SRF signaling pathway is involved in mediating the inhibition of ACTA1 by PAX3-FOXO1. It is a signaling cascade that transmits the inhibitory signals from PAX3-FOXO1 to downregulate the expression of ACTA1.

 How is the ACTA1 protein normally regulated in skeletal muscle? 03/12/2020

The expression and regulation of the ACTA1 protein in skeletal muscle are tightly controlled by various molecular mechanisms, including transcriptional and post-transcriptional processes. These mechanisms ensure proper levels of ACTA1 for muscle function.

What protein composition was observed in the skeletal muscles of Tg(ACTA1)(D286G) mice? 02/10/2020

Mass spectrometry analysis revealed that the skeletal muscles of Tg(ACTA1)(D286G) mice contained approximately 25% of the ACTA1(D286G) protein.

How do ACTA1 mutations affect muscle structure? 01/29/2020

CTA1 mutations can disrupt the normal organization of muscle fibers and sarcomeres, leading to structural abnormalities. These abnormalities can include the presence of nemaline bodies, actin accumulations, and widespread sarcomeric disarray.

What happens when there are mutations in the ACTA1 gene? 12/07/2019

Mutations in the ACTA1 gene can lead to various congenital myopathies, which are muscle disorders present from birth or early infancy. These mutations can disrupt the normal function and structure of skeletal muscles.

What are some of the consequences of ACTA1 mutations? 07/21/2018

ACTA1 mutations can result in severe skeletal muscle weakness, leading to difficulties in movement and muscle function. In some cases, the severity of the mutations can be life-threatening, causing reduced lifespan and early mortality, as seen in certain dominant ACTA1 mutations.

Are there different types of ACTA1 mutations? 04/08/2018

 Yes, there are various types of ACTA1 mutations identified in patients with congenital myopathies. These mutations can have different effects on the structure and function of the ACTA1 protein, leading to a spectrum of clinical presentations and disease severity.

 What is the potential therapeutic implication related to ACTA1 protein load? 04/19/2017

Studies have suggested that altering the ratio of mutant ACTA1 protein to wild-type actin protein in patient muscles may hold promise as a potential therapy for patients with dominant ACTA1 disease

Where is the ACTA1 protein primarily found? 02/06/2017

The ACTA1 protein is primarily found in skeletal muscle, which is responsible for voluntary muscle movement in the body.

What is the significance of the inhibition of ACTA1 by PAX3-FOXO1? 01/06/2016

The inhibition of ACTA1 by PAX3-FOXO1 is believed to play a role in the tumorigenesis and development of alveolar rhabdomyosarcoma (ARMS). It suggests that this regulatory mechanism contributes to the disease progression.

What potential therapy is suggested based on the correlation between mutant ACTA1 protein load and disease severity? 01/02/2016

Altering the ratio of mutant ACTA1 protein to wild-type actin in patient muscle may be a potential therapy for patients with dominant ACTA1 disease.

Customer Reviews (5)

Write a review
Reviews
12/25/2021

    I found the protein product to be highly stable, retaining its functionality even after months of storage, which was crucial for my long-term experiments

    05/11/2021

      The protein product's reliable performance and consistent quality reassured me that it would not introduce any confounding factors or jeopardize the integrity of my experiments.

      04/24/2018

        I found the protein product to be compatible with various downstream applications, such as Western blotting and ELISA, broadening its utility in my researc

        07/12/2017

          I appreciated the convenient packaging of the protein product, with individual aliquots that reduced the need for repeated thawing and freezing.

          11/12/2016

            I appreciated the protein product's consistent performance at the specified concentrations, enabling me to achieve accurate dosing in my experiments

            Ask a Question for All ACTA1 Products

            Required fields are marked with *

            My Review for All ACTA1 Products

            Required fields are marked with *

            0

            Inquiry Basket

            cartIcon
            logo

            FOLLOW US

            Terms and Conditions        Privacy Policy

            Copyright © 2024 Creative BioMart. All Rights Reserved.

            Contact Us

            • /

            Stay Updated on the Latest Bioscience Trends